AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32516300 — intervention group
Group type: EXPERIMENTAL
Intervention: Training to target step length asymmetry
Number of subjects: 48
Study 32516300 — intervention group
Group type: EXPERIMENTAL
Intervention: Training to target stance time asymmetry
Number of subjects: 48
Study 32516300 — intervention group
Group type: EXPERIMENTAL
Intervention: Step length asymmetry improvements
Number of subjects: 48
Study 32516300 — intervention group
Group type: EXPERIMENTAL
Intervention: Stance time asymmetry improvements
Number of subjects: 48
Study 33407195 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped counselling approach for burdened caregivers delivered by care counsellors and registered psychotherapists
Number of subjects: 572
Study 33407195 — intervention group
Group type: COMPARATOR
Intervention: Routine care and counselling (control group)
Number of subjects: 572
Study 32424169 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (30 mins running, 4 days per week for 3 months)
Number of subjects: 39
Study 32424169 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation control group
Number of subjects: 39
Study 35418214 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning programme with face-to-face training and an online module on handover practice (n=50)
Number of subjects: 96
Study 35418214 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group receiving only face-to-face handover training (n=46)
Number of subjects: 96
Study 33872587 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneously once every 4 weeks for 52 weeks
Number of subjects: 414
Study 33872587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 414
Study 32771061 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR (Eye Movement Desensitization and Reprocessing)
Number of subjects: 72
Study 32771061 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study 35803707 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutropenic diet
Number of subjects: 200
Study 35803707 — intervention group
Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 200
Study 33289276 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Oxygen (HFOx)
Number of subjects: 17
Study 33289276 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Air (HFAir)
Number of subjects: 17
Study 33289276 — intervention group
Group type: COMPARATOR
Intervention: Low-Flow Oxygen (LFOx)
Number of subjects: 17
Study 33289276 — intervention group
Group type: COMPARATOR
Intervention: Low-Flow Air (LFAir)
Number of subjects: 17
Study 33745228 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided web-based cognitive behavioral therapy (CBT) program for IBS
Number of subjects: 25
Study 32757687 — intervention group
Group type: EXPERIMENTAL
Intervention: Echo Bi-Metric (EBM) THA stem
Number of subjects: 62
Study 32757687 — intervention group
Group type: COMPARATOR
Intervention: Bi-Metric (BM) THA stem
Number of subjects: 62
Study 34357466 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 80 mg with cisplatin
Number of subjects: 60
Study 34357466 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg with cisplatin
Number of subjects: 60
Study 34357466 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin without pantoprazole (Control group)
Number of subjects: 60
Study 32513018 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT)
Number of subjects: 102
Study 32513018 — intervention group
Group type: COMPARATOR
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 102
Study 35085912 — intervention group
Group type: EXPERIMENTAL
Intervention: EBEKO application (mobile and web-based software system) used for 14 weeks
Number of subjects: 60
Study 35085912 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 33757798 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritlecitinib
Number of subjects: 142
Study 33757798 — intervention group
Group type: EXPERIMENTAL
Intervention: Brepocitinib
Number of subjects: 142
Study 33757798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 34516363 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazil nut supplementation (1 Brazil nut/day)
Number of subjects: 36
Study 32281641 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy during hospitalization
Number of subjects: 0
Study 32281641 — intervention group
Group type: COMPARATOR
Intervention: Nicotine replacement therapy after discharge
Number of subjects: 0
Study 35148036 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body OMT protocol (OMT-WB)
Number of subjects: 45
Study 35148036 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-down OMT protocol (OMT-ND)
Number of subjects: 45
Study 35148036 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment protocol
Number of subjects: 45
Study 34691303 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible ureteroscopy combined with external physical vibration
Number of subjects: 146
Study 34691303 — intervention group
Group type: COMPARATOR
Intervention: Flexible ureteroscopy lithotripsy
Number of subjects: 146
Study 36151727 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple task in simple environment
Number of subjects: 162
Study 36151727 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex task in simple environment
Number of subjects: 162
Study 36151727 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple task in complex environment
Number of subjects: 162
Study 36151727 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex task in complex environment
Number of subjects: 162
Study 32466710 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic drink (0.4 g/kg)
Number of subjects: 88
Study 32466710 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 88
Study 616854348 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping group (KG, tape applied with 40% tension for rectus femoris activation)
Number of subjects: 26
Study 616854348 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, tape applied over rectus femoris without additional tension)
Number of subjects: 26
Study 35339004 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Bundle Branch Pacing (LBBP)
Number of subjects: 50
Study 35339004 — intervention group
Group type: COMPARATOR
Intervention: Right Ventricular Septal Pacing (RVSP)
Number of subjects: 50
Study 32986231 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention for 12 weeks
Number of subjects: 46
Study 32986231 — intervention group
Group type: COMPARATOR
Intervention: Relaxation intervention for 12 weeks
Number of subjects: 46
Study 37318120 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with 8 mg intravenous ondansetron
Number of subjects: 212
Study 37318120 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron alone
Number of subjects: 212
Study 37318120 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with ondansetron
Number of subjects: 212
Study 37318120 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 212
Study 32333793 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (2.5 g daily for four months)
Number of subjects: 65
Study 32333793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 32940710 — intervention group
Group type: EXPERIMENTAL
Intervention: Trialstreamer system for finding and categorizing RCTs
Number of subjects: 673191
Study 32940710 — intervention group
Group type: EXPERIMENTAL
Intervention: Trialstreamer system
Number of subjects: 673191
Study 34313366 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle training package (60-90 min group training, educational booklet, text messages)
Number of subjects: 140
Study 34313366 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle training package
Number of subjects: 140
Study 34108247 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide
Number of subjects: 24
Study 34108247 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% nitrous oxide
Number of subjects: 24
Study 34108247 — intervention group
Group type: COMPARATOR
Intervention: Placebo (air/oxygen)
Number of subjects: 24
Study 32682559 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEPmaxCrs
Number of subjects: 37
Study 32682559 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised PEEP (PEEPmaxCrs and PEEPPtp_ee combined)
Number of subjects: 37
Study 32682559 — intervention group
Group type: COMPARATOR
Intervention: Control (PEEP≤2 cm H2O)
Number of subjects: 37
Study 34428118 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Training (10-week program)
Number of subjects: 39
Study 34428118 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study 33260552 — intervention group
Group type: EXPERIMENTAL
Intervention: Oolong tea (100 mg caffeine, 21.4 mg gallic acid, 97 mg catechins, 125 mg polymerized polyphenol)
Number of subjects: 12
Study 33260552 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 12
Study 33260552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 34058114 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors
Number of subjects: 0
Study 34058114 — intervention group
Group type: COMPARATOR
Intervention: GLP-1 receptor agonists
Number of subjects: 0
Study 34272336 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation (quitters)
Number of subjects: 2273
Study 32665528 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 100 U
Number of subjects: 0
Study 32665528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32380994 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip abductor strengthening exercises combined with quadriceps strengthening exercises
Number of subjects: 86
Study 32380994 — intervention group
Group type: COMPARATOR
Intervention: Standalone quadriceps strengthening exercises
Number of subjects: 86
Study 35761199 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialysis exercise program with non-immersive virtual reality for 3 months
Number of subjects: 0
Study 34693501 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.2 mg/kg three times daily, administered 15 min before feeding, up to term.
Number of subjects: 466
Study 34693501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 466
Study 32064708 — intervention group
Group type: EXPERIMENTAL
Intervention: ACO (defined by various definitions including atopy and physician diagnosis of asthma)
Number of subjects: 522
Study 32064708 — intervention group
Group type: COMPARATOR
Intervention: Non-ACO (control group)
Number of subjects: 522
Study 36172027 — intervention group
Group type: EXPERIMENTAL
Intervention: Idebenone (30 mg each time, three times a day)
Number of subjects: 142
Study 36172027 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 142
Study 35379286 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial vasodilatory therapy (prostaglandin infusion)
Number of subjects: 42
Study 32430540 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (male: 0.55 g/kg, female: 0.45 g/kg)
Number of subjects: 111
Study 32430540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 32430540 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 111
Study 32348239 — intervention group
Group type: EXPERIMENTAL
Intervention: LAPIP protocol
Number of subjects: 222
Study 36350802 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction program for chronic back pain (MBSR-CBP)
Number of subjects: 96
Study 33565516 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONSs)
Number of subjects: 52
Study 33565516 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ONSs)
Number of subjects: 52
Study 36358943 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnenolone (PREG) 500 mg/day
Number of subjects: 30
Study 36358943 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnenolone (PREG) 300 mg/day
Number of subjects: 30
Study 36358943 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 30
Study 33353913 — intervention group
Group type: EXPERIMENTAL
Intervention: 31 gauge needle (31GN)
Number of subjects: 100
Study 33353913 — intervention group
Group type: EXPERIMENTAL
Intervention: 31 gauge needle with topical lignocaine‐prilocaine (31GT)
Number of subjects: 100
Study 33353913 — intervention group
Group type: COMPARATOR
Intervention: 27 gauge needle (27GN)
Number of subjects: 100
Study 33353913 — intervention group
Group type: COMPARATOR
Intervention: 27 gauge needle with topical lignocaine‐prilocaine (27GT)
Number of subjects: 100
Study 33353913 — intervention group
Group type: EXPERIMENTAL
Intervention: 31GN
Number of subjects: 100
Study 33353913 — intervention group
Group type: EXPERIMENTAL
Intervention: 31GT
Number of subjects: 100
Study 33353913 — intervention group
Group type: COMPARATOR
Intervention: 27GN
Number of subjects: 100
Study 33353913 — intervention group
Group type: COMPARATOR
Intervention: 27GT
Number of subjects: 100
Study 35796486 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (75 mg) with 1 mg midazolam
Number of subjects: 66
Study 35796486 — intervention group
Group type: COMPARATOR
Intervention: Standard Moderate Sedation (SMS) with midazolam and fentanyl (150 mcg fentanyl, 5 mg midazolam)
Number of subjects: 66
Study 34143669 — intervention group
Group type: EXPERIMENTAL
Intervention: Crazy Taxi (CT)
Number of subjects: 0
Study 34143669 — intervention group
Group type: EXPERIMENTAL
Intervention: PositScience InSight
Number of subjects: 0
Study 34143669 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 0
Study 32687974 — intervention group
Group type: EXPERIMENTAL
Intervention: Seamos Activas II intervention (theory- and technology-enhanced physical activity intervention)
Number of subjects: 199
Study 32687974 — intervention group
Group type: COMPARATOR
Intervention: Seamos Saludables PA print intervention (control)
Number of subjects: 199
Study 32687974 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported MVPA
Number of subjects: 199
Study 32687974 — intervention group
Group type: EXPERIMENTAL
Intervention: Objectively measured MVPA
Number of subjects: 199
Study 34859459 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous selenium supplementation (3000 mcg after anesthesia induction, 1000 mcg upon ICU admission, and 1000 mcg daily in the ICU for a maximum of 14 days)
Number of subjects: 20
Study 34859459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32471143 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum ANP levels >64.6 pg/mL
Number of subjects: 0
Study 32471143 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum NT-proCNP levels >1.7 pg/mL
Number of subjects: 0
Study 32471143 — intervention group
Group type: EXPERIMENTAL
Intervention: Natriuretic peptides (ANP and NT-proCNP)
Number of subjects: 0
Study 35037049 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal PCV-10
Number of subjects: 347
Study 35037049 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal PPV-23
Number of subjects: 347
Study 35037049 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal Placebo
Number of subjects: 347
Study 33036845 — intervention group
Group type: COMPARATOR
Intervention: Opioid-only (OO) regimen
Number of subjects: 216
Study 33036845 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal pain management (MMPM) regimen
Number of subjects: 216
Study 36174873 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning algorithm based on YOLOv5 detection model
Number of subjects: 200
Study 33785406 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) with traumatic memory reactivation
Number of subjects: 28
Study 33785406 — intervention group
Group type: COMPARATOR
Intervention: Electroconvulsive therapy (ECT) with non-traumatic memory reactivation
Number of subjects: 28
Study 33785406 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in heart rate while listening to the script
Number of subjects: 28
Study 35585705 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally and contextually situated multimedia approach
Number of subjects: 60
Study 35094095 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 264
Study 35094095 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace Dialog Intervention (WDI)
Number of subjects: 264
Study 35094095 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT + WDI
Number of subjects: 264
Study 35094095 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 264
Study 33000326 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 70
Study 33000326 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 70
Study 35862395 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in herbal remedy clinical trial
Number of subjects: 30
Study 34398796 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-supported platform, Medication Housekeeper (MediHK) for 4 weeks, including daily pain diaries, ADR forms every 3 days, and Brief Pain Inventory every 15 days.
Number of subjects: 100
Study 34398796 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-supported platform, Medication Housekeeper (MediHK) for 4 weeks.
Number of subjects: 100
Study 34398796 — intervention group
Group type: COMPARATOR
Intervention: Conventional care without reminders to fill out forms.
Number of subjects: 100
Study 32499552 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective selective carious tissue removal using hand instruments (S)
Number of subjects: 115
Study 32499552 — intervention group
Group type: COMPARATOR
Intervention: Objective selective carious tissue removal using a self-limiting polymer bur (O)
Number of subjects: 115
Study 32499552 — intervention group
Group type: EXPERIMENTAL
Intervention: Both S and O interventions
Number of subjects: 115
Study 35182889 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive-behavioral therapy (ICBT) (iSOMA) for 8 weeks
Number of subjects: 156
Study 35182889 — intervention group
Group type: COMPARATOR
Intervention: waitlist control group (WL)
Number of subjects: 156
Study 34896645 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-disciplinary clinic care
Number of subjects: 188
Study 34896645 — intervention group
Group type: COMPARATOR
Intervention: Standard-care
Number of subjects: 188
Study 33599356 — intervention group
Group type: EXPERIMENTAL
Intervention: E6011 (12-week multiple ascending dose phase: 2, 5, 10, and 15 mg/kg intravenously every 2 weeks)
Number of subjects: 28
Study 33599356 — intervention group
Group type: EXPERIMENTAL
Intervention: E6011 (12-week multiple ascending dose phase)
Number of subjects: 28
Study 33599356 — intervention group
Group type: EXPERIMENTAL
Intervention: E6011 (40-week Extension phase at the same dose as MAD phase)
Number of subjects: 28
Study 33599356 — intervention group
Group type: EXPERIMENTAL
Intervention: E6011 (during the study)
Number of subjects: 28
Study 33248978 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 232
Study 33248978 — intervention group
Group type: COMPARATOR
Intervention: Drug-Eluting Stent (EES)
Number of subjects: 232
Study 36283712 — intervention group
Group type: EXPERIMENTAL
Intervention: Pudendal block
Number of subjects: 60
Study 36283712 — intervention group
Group type: COMPARATOR
Intervention: Caudal block
Number of subjects: 60
Study 35351839 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical Disk Arthroplasty (CDA)
Number of subjects: 384
Study 35351839 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally Invasive Posterior Cervical Foraminotomy (MI‐PCF)
Number of subjects: 384
Study 35351839 — intervention group
Group type: EXPERIMENTAL
Intervention: Open Posterior Cervical Foraminotomy (O‐PCF)
Number of subjects: 384
Study 35351839 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior Cervical Decompression and Fusion (ACDF)
Number of subjects: 384
Study 35351839 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 384
Study 32406965 — intervention group
Group type: EXPERIMENTAL
Intervention: CHoBI7 mHealth program (mobile messages)
Number of subjects: 1777
Study 35441808 — intervention group
Group type: EXPERIMENTAL
Intervention: taVNS (left ear, 10 Hz, 300 µs, 2.0–2.5 mA, 30 min)
Number of subjects: 26
Study 35441808 — intervention group
Group type: COMPARATOR
Intervention: sham-taVNS (electrode attached to ear with the stimulator turned off)
Number of subjects: 26
Study 33753275 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (open reduction and screw fixation)
Number of subjects: 45
Study 33753275 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (pressure bandage)
Number of subjects: 45
Study 32243100 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan add-on (n = 25)
Number of subjects: 51
Study 32243100 — intervention group
Group type: COMPARATOR
Intervention: Conventional diuretic therapy (n = 26)
Number of subjects: 51
Study 34537912 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing and Cognitive Behavioral intervention (Project PLUS), 6 sessions
Number of subjects: 84
Study 34537912 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 84
Study 34537912 — intervention group
Group type: COMPARATOR
Intervention: No-Intervention comparison cohort
Number of subjects: 84
Study 33632926 — intervention group
Group type: EXPERIMENTAL
Intervention: gilteritinib
Number of subjects: 138
Study 33002002 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-exposed infants
Number of subjects: 1852
Study 33002002 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-exposed children
Number of subjects: 1852
Study 33002002 — intervention group
Group type: COMPARATOR
Intervention: HIV-unexposed children
Number of subjects: 1852
Study 33002002 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure of mother’s HIV status
Number of subjects: 1852
Study 32773594 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol extended-release (ER) 50 mg × 2
Number of subjects: 134
Study 32773594 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone controlled-release (CR) 10 mg × 2
Number of subjects: 134